{
    "nctId": "NCT04145817",
    "briefTitle": "Breast Cancer Risk After Diagnostic Gene Sequencing",
    "officialTitle": "Clinical Application of the European Horizon 2020 Research Project \"BRIDGES\" - Study of the Psychological Impact of Breast Cancer Risk Communication in Cancer Genetics Based on the Personalized Estimation of the BOADICEA V5/PLUS Model",
    "overallStatus": "COMPLETED",
    "conditions": "Genetic Predisposition to Disease",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "PREVENTION",
    "enrollmentCount": 405,
    "primaryOutcomeMeasure": "Psychosocial Assessment in Hereditary Cancer questionnaire (PAHC).",
    "eligibilityCriteria": "Inclusion Criteria:\n\n1. Healthy woman, relative of a family member first tested (index case) who received a positive genetic test result (presence of a BRCA1 or BRCA2 deleterious variant or a moderate-penetrance BC gene deleterious variant) ;\n\n   a. at Cologne University Hospital (Germany), these healthy women may also be relatives of women (index case) who received a negative non-informative test result;\n2. Who accept BRIDGES gene panel testing and the breast cancer risk PRS;\n3. Aged 18 years or over with no upper limit;\n4. Able to give informed written consent in accordance with national/local regulations and procedures;\n5. Able to understand the questionnaire language of the participating genetic clinic.\n\nExclusion Criteria:\n\n1. Woman affected with BC, with recurrent BC, with metastatic BC, with an ovarian cancer (OC) or cancer of any other site;\n2. Aged under 18 years old;\n3. Unable to give informed written consent;\n4. Unable to understand the questionnaire language of the participating clinic;\n5. Unable to answer the questionnaire due to physical or cognitive disturbance",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}